Follow
Bert van der Vegt
Bert van der Vegt
University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Verified email at umcg.nl - Homepage
Title
Cited by
Cited by
Year
Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
SQ Qiu, SJH Waaijer, MC Zwager, EGE de Vries, B van der Vegt, ...
Cancer treatment reviews 70, 178-189, 2018
2592018
Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility StudyTargeted Near-Infrared Fluorescence …
LE Lamberts, M Koch, JS de Jong, ALL Adams, J Glatz, MEG Kranendonk, ...
Clinical Cancer Research 23 (11), 2730-2741, 2017
2102017
Heart failure stimulates tumor growth by circulating factors
WC Meijers, M Maglione, SJL Bakker, R Oberhuber, LM Kieneker, ...
Circulation 138 (7), 678-691, 2018
1722018
Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment
K Delli, EA Haacke, FGM Kroese, RP Pollard, S Ihrler, B van der Vegt, ...
Annals of the Rheumatic Diseases 75 (11), 1933-1938, 2016
1022016
Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers
M Koller, SQ Qiu, MD Linssen, L Jansen, W Kelder, J de Vries, I Kruithof, ...
Nature communications 9 (1), 1-11, 2018
912018
89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
F Bensch, AH Brouwers, MN Lub-de Hooge, JR de Jong, B van der Vegt, ...
European journal of nuclear medicine and molecular imaging 45 (13), 2300-2306, 2018
772018
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement
T Koopman, HJ Buikema, H Hollema, GH de Bock, B van der Vegt
Breast cancer research and treatment 169 (1), 33-42, 2018
762018
Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery
FJ Voskuil, PJ Steinkamp, T Zhao, B van der Vegt, M Koller, JJ Doff, ...
Nature communications 11 (1), 1-10, 2020
752020
Germinal centres in diagnostic labial gland biopsies of patients with primary Sjögren’s syndrome are not predictive for parotid MALT lymphoma development
EA Haacke, B van der Vegt, A Vissink, FKL Spijkervet, H Bootsma, ...
Annals of the Rheumatic Diseases 76 (10), 1781-1784, 2017
712017
Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma
H Hartog, HM Horlings, B van der Vegt, B Kreike, A Ajouaou, ...
Breast cancer research and treatment 129 (3), 725-736, 2011
712011
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma
B Van Der Vegt, MAJ De Roos, JL Peterse, C Patriarca, J Hilkens, ...
Histopathology 51 (3), 322-335, 2007
692007
B cell depletion therapy normalizes circulating follicular TH cells in primary Sjögren syndrome
GM Verstappen, FGM Kroese, PM Meiners, OB Corneth, MG Huitema, ...
The Journal of rheumatology 44 (1), 49-58, 2017
652017
Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast
MA de Roos, B van der Vegt, J de Vries, J Wesseling, GH de Bock
Annals of surgical oncology 14 (7), 2097-2104, 2007
592007
p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast
MA de Roos, GH de Bock, J de Vries, B van der Vegt, J Wesseling
Journal of Surgical Research 140 (1), 109-114, 2007
572007
Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)
JF van Nimwegen, E Mossel, GS van Zuiden, RF Wijnsma, K Delli, AJ Stel, ...
The Lancet Rheumatology 2 (3), e153-e163, 2020
562020
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration
SCY Leung, TO Nielsen, LA Zabaglo, I Arun, SS Badve, AL Bane, ...
Histopathology 75 (2), 225-235, 2019
542019
Axillary recurrence after sentinel lymph node biopsy
B van der Vegt, MHE Doting, PL Jager, J Wesseling, J de Vries
European Journal of Surgical Oncology (EJSO) 30 (7), 715-720, 2004
512004
Androgen and estrogen receptor imaging in metastatic breast cancer patients as a surrogate for tissue biopsies
CM Venema, LH Mammatas, CP Schröder, M van Kruchten, G Apollonio, ...
Journal of Nuclear Medicine 58 (12), 1906-1912, 2017
462017
Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye
LJ Melchers, MF Mastik, B Samaniego Cameron, BAC Van Dijk, ...
British journal of cancer 112 (8), 1349-1357, 2015
452015
Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: a quantitative dose-escalation study
FJ Voskuil, SJ de Jongh, WTR Hooghiemstra, MD Linssen, PJ Steinkamp, ...
Theranostics 10 (9), 3994, 2020
442020
The system can't perform the operation now. Try again later.
Articles 1–20